Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement

Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med, 382, 727, 10.1056/NEJMoa2001017 Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7 Xu, 2020, Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir Med, 8, 420, 10.1016/S2213-2600(20)30076-X Chau, 2004, SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases, Hepatology, 39, 302, 10.1002/hep.20111 Mallapaty, 2020, Why does the coronavirus spread so easily between people?, Nature, 579, 183, 10.1038/d41586-020-00660-x Zhang, 2020, Specific ACE2 expression in small intestinal enterocytes cause gastrointestinal symptoms and injury after 2019-nCoV infection, Int J Infect Dis, 96, 19, 10.1016/j.ijid.2020.04.027 Moon, 2020, High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry, J Hepatol, 10.1016/j.jhep.2020.05.013 2018, Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study, Lancet Gastroenterol Hepatol, 3, 383, 10.1016/S2468-1253(18)30056-6 Sarin, 2020, Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission, Lancet Gastroenterol Hepatol, 5, 167, 10.1016/S2468-1253(19)30342-5 2020, The protocol for prevention, diagnosis and treatment of liver injury in coronavirus disease 2019, Chin J Hepatol, 28, 217 Lau, 2020, Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations, Hepatol Int, 10.1007/s12072-020-10054-w Boettler, 2020, Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper, JHEP Rep, 2 Li, 2020, Therapeutic options for the 2019 novel coronavirus (2019-nCoV), Nat Rev Drug Discov, 19, 149, 10.1038/d41573-020-00016-0 Sagonowsky Chu, 2004, Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings, Thorax, 59, 252, 10.1136/thorax.2003.012658 Cao, 2020, A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19, N Engl J Med, 382, 1787, 10.1056/NEJMoa2001282 Bijlsma, 2016, Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial, Lancet, 388, 343, 10.1016/S0140-6736(16)30363-4 Palacios, 2006, Low incidence of severe liver events in HIV patients with and without hepatitis C or B coinfection receiving lopinavir/ritonavir, HIV Clin Trials, 7, 319, 10.1310/hct0706-319 Grein, 2020, Compassionate use of remdesivir for patients with severe Covid-19, N Engl J Med, 382, 2327, 10.1056/NEJMoa2007016 Sun, 2020, COVID-19 and liver disease, Liver Int, 40, 1278, 10.1111/liv.14470 Sonneveld, 2019, Fulminant liver failure due to hepatitis B reactivation during treatment with tocilizumab, ACG Case Rep J, 6, 10.14309/crj.0000000000000243 Andrade, 2019, EASL clinical practice guidelines: drug-induced liver injury, J Hepatol, 70, 1222, 10.1016/j.jhep.2019.02.014 Fontana, 2010, Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop, Hepatology, 52, 730, 10.1002/hep.23696 Fan, 2020, Clinical features of COVID-19-related liver damage, Clin Gastroenterol Hepatol, 18, 1561, 10.1016/j.cgh.2020.04.002 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Shi, 2020, Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study, Lancet Infect Dis, 20, 425, 10.1016/S1473-3099(20)30086-4 Xu, 2020, Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series, BMJ, 368, m606, 10.1136/bmj.m606 Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med, 8, 475, 10.1016/S2213-2600(20)30079-5 Wrapp, 2020, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science, 367, 1260, 10.1126/science.abb2507 Li, 2019, Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis, Lancet Gastroenterol Hepatol, 4, 389, 10.1016/S2468-1253(19)30039-1 2017, Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study, Lancet Gastroenterol Hepatol, 2, 161, 10.1016/S2468-1253(16)30181-9 Xu, 2020, Liver injury during highly pathogenic human coronavirus infections, Liver Int, 40, 998, 10.1111/liv.14435 Shang, 2020, On the use of corticosteroids for 2019-nCoV pneumonia, Lancet, 395, 683, 10.1016/S0140-6736(20)30361-5 Wong, 2019, Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B, Liver Int, 39, 271, 10.1111/liv.13953 Lampertico, 2017, EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection, J Hepatol, 67, 370, 10.1016/j.jhep.2017.03.021 Sarin, 2016, Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update, Hepatol Int, 10, 1, 10.1007/s12072-015-9675-4 Terrault, 2018, Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance, Hepatology, 67, 1560, 10.1002/hep.29800 Wong, 2018, Review article: long-term safety of oral anti-viral treatment for chronic hepatitis B, Aliment Pharmacol Ther, 47, 730, 10.1111/apt.14497 Chong, 2017, When can we stop nucleoside analogues in patients with chronic hepatitis B?, Liver Int, 37, 52, 10.1111/liv.13314 Wong, 2020, The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg-negative chronic hepatitis B, Liver Int, 40, 549, 10.1111/liv.14330 Seto, 2015, Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study, Gut, 64, 667, 10.1136/gutjnl-2014-307237 Marshall, 2018, Lack of patient compliance in real-world practice negatively affects sustained viral response rates to direct acting agent therapy for hepatitis C, Dig Dis Sci, 63, 3228, 10.1007/s10620-018-5247-5 Huang, 2020, Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy, Clin Mol Hepatol, 10.3350/cmh.2020.0018 Zhou, 2020, Younger patients with MAFLD are at increased risk of severe COVID-19 illness: a multicenter preliminary analysis, J Hepatol, 10.1016/j.jhep.2020.04.027 Zhou, 2020, Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China, Metabolism, 107, 10.1016/j.metabol.2020.154216 Finfer, 2009, Intensive versus conventional glucose control in critically ill patients, N Engl J Med, 360, 1283, 10.1056/NEJMoa0810625 Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 394, 10.3322/caac.21492 Wong, 2008, Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis, Liver Int, 28, 79, 10.1111/j.1478-3231.2007.01576.x Wang, 2013, Hepatocellular carcinoma surveillance at 4- vs 12-month intervals for patients with chronic viral hepatitis: a randomized study in community, Am J Gastroenterol, 108, 416, 10.1038/ajg.2012.445 Emanuel, 2020, Fair allocation of scarce medical resources in the time of Covid-19, N Engl J Med, 382, 2049, 10.1056/NEJMsb2005114 Chiu, 2020, Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements), Gut, 69, 991, 10.1136/gutjnl-2020-321185 Lui, 2020, Overview of guidance for endoscopy during the coronavirus disease 2019 pandemic, J Gastroenterol Hepatol, 35, 749, 10.1111/jgh.15053 Poordad, 2015, Presentation and complications associated with cirrhosis of the liver, Curr Med Res Opin, 31, 925, 10.1185/03007995.2015.1021905 Sung, 2003, Treatment of variceal bleeding, Curr Treat Options Gastroenterol, 6, 171, 10.1007/s11938-003-0018-5 de Franchis, 2015, Expanding consensus in portal hypertension: report of the Baveno VI Consensus workshop: stratifying risk and individualizing care for portal hypertension, J Hepatol, 63, 743, 10.1016/j.jhep.2015.05.022 Petta, 2018, Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis, J Hepatol, 69, 878, 10.1016/j.jhep.2018.05.019 Wong, 2018, A new screening strategy for varices by liver and spleen stiffness measurement (LSSM) in cirrhotic patients: a randomized trial, Liver Int, 38, 636, 10.1111/liv.13560 Wong, 2019, Low risk of variceal bleeding in patients with cirrhosis after variceal screening stratified by liver/spleen stiffness, Hepatology, 70, 971, 10.1002/hep.30522 Zheng, 2019, The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study, BMC Gastroenterol, 19, 32, 10.1186/s12876-019-0943-y Gattini, 2020, Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis, Cochrane Database Syst Rev, 1 Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3 Bhoori, 2020, COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy, Lancet Gastroenterol Hepatol, 5, 532, 10.1016/S2468-1253(20)30116-3 Belli, 2020, COVID-19 in liver transplant recipients: preliminary data from the ELITA/ELTR registry, Lancet Gastroenterol Hepatol, 10.1016/S2468-1253(20)30183-7 Fix, 2020, Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement, Hepatology, 10.1002/hep.31281 Ertel, 2016, Use of video-based education and tele-health home monitoring after liver transplantation: results of a novel pilot study, Surgery, 160, 869, 10.1016/j.surg.2016.06.016 Serper, 2020, Telemedicine in liver disease and beyond: can the COVID-19 crisis lead to action?, Hepatology, 10.1002/hep.31276 Stein, 2020, COVID-19 and rationally layered social distancing, Int J Clin Pract, 10.1111/ijcp.13501 Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 323, 1061, 10.1001/jama.2020.1585 Kumar, 2020, COVID-19: a global transplant perspective on successfully navigating a pandemic, Am J Transplant, 10.1111/ajt.15876 Qin, 2020, Perioperative presentation of COVID-19 disease in a liver transplant recipient, Hepatology, 10.1002/hep.31257 D'Antiga, 2020, Coronaviruses and immunosuppressed patients: the facts during the third epidemic, Liver Transpl, 26, 832, 10.1002/lt.25756 Gandhi, 2020, Asymptomatic transmission, the achilles' heel of current strategies to control Covid-19, N Engl J Med, 382, 2158, 10.1056/NEJMe2009758